Taken together, these findings suggest that ATF3, CDKN1A/P21, IL6 are key regulatory hub genes that modulate multiple pathological mechanisms in PMD, including ferroptosis, apoptosis, pyroptosis, cell senescence, ECM degradation, and inflammation. This evidence concerns the gene CDKN1A and Pelizeaus-Merzbacher spectrum disorder.